CGC
Canopy Growth Corp
NASDAQ · Pharmaceuticals
$1.10
+0.02 (+1.85%)
Open$1.09
Previous Close$1.08
Day High$1.14
Day Low$1.08
52W High$4.15
52W Low$1.09
Volume—
Avg Volume1.86M
Market Cap569.01M
P/E Ratio—
EPS$-1.84
SectorPharmaceuticals
Analyst Ratings
Strong Sell
13 analysts
Price Target
+2,036.4% upside
Current
$1.10
$1.10
Target
$23.50
$23.50
$17.63
$23.50 avg
$33.45
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 1.29B | 1.60B | 165.63M |
| Net Income | -2,876,660,469 | -3,204,994,332 | 21.61M |
| Profit Margin | -222.4% | -211.2% | 13.1% |
| EBITDA | -520,955,343 | -612,661,024 | 29.60M |
| Free Cash Flow | — | — | 16.40M |
| Rev Growth | -19.2% | -19.2% | +8.2% |
| Debt/Equity | 0.67 | 0.67 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |